Novo Nordisk reduces Wegovy prices by 50% and Ozempic by 35%
Novo Nordisk announced it will reduce the prices of its weight-loss drugs Wegovy and Ozempic by up to 50%, effective ...
Novo Nordisk announced it will reduce the prices of its weight-loss drugs Wegovy and Ozempic by up to 50%, effective ...
Novo Nordisk will reduce the U.S. list prices of its diabetes and weight-loss medications, Ozempic and Wegovy, by up to ...
Novo Nordisk reported strong demand for its Wegovy pill, which launched in the U.S. in January, with about 50,000 prescriptions ...
The pharmaceutical sector is witnessing significant attention on GLP-1 weight-loss drugs, with Novo Nordisk (NYSE: NVO) initially leading the market. ...
A pill form of the weight-loss drug Wegovy, produced by Novo Nordisk, is now available in the U.S. at a ...
Shares of Novo Nordisk (NYSE: NVO) rose 3.5% on Monday, coinciding with gains in the S&P 500 and Nasdaq Composite. ...
Several applications for generic semaglutide, the active ingredient in Novo Nordisk's Ozempic and Wegovy, are currently under review by Health ...
Shares of Denmark's pharmaceutical company Novo Nordisk (NYSE: NVO) fell by 4% following the termination of its partnership with telehealth ...
Novo Nordisk has terminated its partnership with Hims & Hers Health due to allegations of the telehealth company selling counterfeit ...
Novo Nordisk (NVO -1.69%), known for its GLP-1 weight loss drugs Ozempic and Wegovy, saw a 2% decline after Reuters ...
Copyright © 2026 News Wave
News Wave is not responsible for the content of external sites.